The Cognitive-behavioral Approach, Standard Plan Security on Relapse Suicidal Adolescents
NCT ID: NCT02963870
Last Updated: 2018-08-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
338 participants
INTERVENTIONAL
2017-05-31
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Community-Based Cognitive Therapy for Suicide Attempters
NCT00081367
Cognitive Behavioural Group Therapy Versus Individual Supportive Therapy for the Prevention of Repeat Suicide Attempts
NCT02664701
An Initial Feasibility Study of Brief Cognitive Behavioral Therapy for Suicidal Inpatients
NCT03442699
Mindfulness Based Cognitive Therapy for Depression and Cognitive Inhibition in Suicide
NCT02954250
RCT of the Clinical and Cost Effectiveness of Cognitive Behaviour Therapy (CBT) Delivered Remotely Versus Treatment as Usual in Adolescents and Young Adults With Depression Who Repeatedly Self-harm
NCT02377011
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Since 2009, our team is engaged in a partnership between France and Quebec Interuniversity agreement concluded by a University Picardie Jules Verne-University of Montreal. In this context, two teams G4 (Amiens and Rouen) have received training in suicidal crisis, including the security plan by a university instructor and TCC Québec, Dr. Labelle. Furthermore, we complete a descriptive and prospective study of risk and protective factors for adolescent suicide in which the Quebec team of Professor Labelle contributes as an expert (sponsor: Rouen). 200 subjects were recruited on 2 years by 3 (CHU Amiens, CH Compiègne, CHU Rouen) with an assessment of recurrence at 1 year (lost rates of view = 15%). The first results highlight the central role of personal coping strategies (coping) in suicidal recurrence. We want extend this study to validate the implementation of the security plan (safety level) with suicidal adolescents. The security plan is the initial step of the TCC approach short of suicidal crisis. It is established after working with adolescents and their families (chain analysis of the suicidal crisis, coping self-evaluation and identification of support resources). Developed by Stanley B from Columbia University and adapted for francophone adolescents R Labelle and JJ Breton wrote this list those resources and coping strategies to apply in case ideation and suicidal crisis. Signed by the young person and his family, he then uses to frame the monitoring and management plan of the youth and his family environment, friendly and professional in case of suicidal crisis.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
security plan
groups of adolescents aged 12-17 hospitalized for TS and randomized to a group treated with security plan and the usual treatment
Security Plan
This study compared two groups of adolescents aged 12-17 hospitalized for TS and randomized to a group treated with the Security Plan plus the usual treatment and a group receiving standard treatment only.
standard treatment only.
group receiving standard treatment only.
Security Plan
This study compared two groups of adolescents aged 12-17 hospitalized for TS and randomized to a group treated with the Security Plan plus the usual treatment and a group receiving standard treatment only.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Security Plan
This study compared two groups of adolescents aged 12-17 hospitalized for TS and randomized to a group treated with the Security Plan plus the usual treatment and a group receiving standard treatment only.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Adolescents whose parents gave informed consent and who themselves expressed their willingness to participate in research.
* Patients covered by the social insurance system
Exclusion Criteria
* mental disorders significantly impair the self-assessment questionnaire capacities: Intellectual disability, autism spectrum disorder, acute psychotic state and, psychopathy (including assessment questionnaire Frick) and the active use of alcohol and toxic (DEP teen\> 20)
* have benefited a security plan before the study
* adolescents deprived of liberty.
12 Years
17 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire, Amiens
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jean-Marc GUILE, professor
Role: STUDY_DIRECTOR
CHU amiens-Picardie
LEGRAND, Doctor
Role: PRINCIPAL_INVESTIGATOR
CHP Philippe Pinel Amiens
GERARDIN, Doctor
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Rouen
BALEYTE, Doctor
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Caen
Bernadette BAKHACHE, Doctor
Role: PRINCIPAL_INVESTIGATOR
CH St-Quentin
Maud PERCQ, Doctor
Role: PRINCIPAL_INVESTIGATOR
EPSMD Aisne
VERVEL, Doctor
Role: PRINCIPAL_INVESTIGATOR
CH Compiègne
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chu Amiens Picardie
Amiens, , France
CHU CAEN
Caen, , France
Chu Charles Nicolle
Rouen, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Jean-marc GUILE, PhD
Role: primary
Jean-marc BALEYTE, PhD
Role: primary
Priscille GERARDIN, PhD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PI2015_843_0009
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.